-+ 0.00%
-+ 0.00%
-+ 0.00%

JAYPIRCA® (PIRTOBRUTINIB) APPROVED IN CHINA FOR THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

路透·03/02/2026 00:00:00

登录查看新闻详情